Molecular definition of chromosome translocations involving 10q24 and 19q13 in human malignant glioma cells

Cancer Genetics and Cytogenetics

Volumn 105, Issue 1, 1998, Pages 60-68

  Chernova, Olga ^a   Cowell, John K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; ASTROCYTOMA; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 19Q; CHROMOSOME BREAKAGE; CHROMOSOME PAINTING; CHROMOSOME TRANSLOCATION 10; FLUORESCENCE IN SITU HYBRIDIZATION; GLIOMA; GLIOMA CELL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

BRAIN NEOPLASMS; CHROMOSOME BREAKAGE; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 19; CLONE CELLS; GENE REARRANGEMENT; GLIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032146571     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00479-2     Document Type: Article

References (37)

1. Collins V.P. Genetic alterations in gliomas. J Neurooncol. 24:1995;37-38.
2. Hecht B.K., Turc-Carel C., Chatel M., Grellier P., Gioanni J., Attias R., Gaudray P., Hecht F. Cytogenetics of malignant gliomas. II. the autosomes with reference to rearrangements Cancer Genet Cytogenet. 84:1995;1-8.
3. Cavenee W.K., Dryja T.P., Phillips R.A., Benedict W.F., Godbout R., Gallie B.L., Murphree A.L., Strong L.C., White R.L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305:1983;779-784.
4. James C.D., Carlbom E., Dumanski J.P., Hansen M., Nordenskjold M., Collins V.P., Cavenee W.K. Clonal genomic alterations in glioma malignancy stages. Cancer Res. 48:1988;5546-5551.
5. Fults D., Pedone C.A., Thomas G.A., White R. Allelotype of human malignant astrocytoma. Cancer Res. 50:1990;5784-5789.
6. Rasheed B.K., Fuller G.N., Friedman A.H., Bigner D.D., Bigner S.H. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosom Cancer. 5:1992;75-82.
7. Albarosa R., Colombo B.M., Roz L., Magnani I., Pollo B., Cirenei N., Giani C., Conti A.M., DiDonato S., Finocchiaro G. Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am J Hum Genet. 58:1996;1260-1267.
8. Ransom D.T., Ritland S.R., Moertel C.A., Dahl R.J., O'Fallon J.R., Scheithauer B.W., Kimmel D.W., Kelly P.J., Olopade O.I., Diaz M.O., Jenkins R.B. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosom Cancer. 5:1992;357-374.
9. Karlbom A.E., James C.D., Boethius J., Cavenee W.K., Collins V.P., Nordenskjold M., Larsson C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet. 92:1993;169-174.
10. Fults D., Pedone C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosom Cancer. 7:1993;173-177.
11. Pershouse M.A., Stubblefield E., Hadi A., Killary A.M., Yung W.K.A., Steck P.A. Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res. 53:1993;5043-5050.
12. Steck P.A., Ligon A.H., Cheong P., Yung W.K., Pershouse M.A. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosom Cancer. 12:1995;255-261.
13. Bigner S.H., Mark J., Burger P.C., Mahaley M., Bullard D.E., Muhlbaier L.H., Bigner D.D. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res. 48:1988;405-411.
14. Ransom D.T., Ritland S.R., Kimmel D.W., Moertel C.A., Dahl R.J., Scheithauer B.W., Kelly P.J., Jenkins R.B. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas and oligodendrogliomas. Genes Chromosom Cancer. 5:1992;348-356.
15. von Deimling A., Bender B., Jahnke R., Waha A., Kraus J., Albrecht S., Wellenreuther R., Fassbender F., Nagel J., Menon A.G., Louis D.N., Lenartz D., Schramm J., Wiestler O.D. Loci associated with malignant progression in astrocytomas. a candidate on chromosome 19q Cancer Res. 54:1994;1397-1401.
16. Ritland S.R., Ganju V., Jenkins R.B. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosom Cancer. 12:1995;277-282.
17. Kraus J.A., Koopman J., Kaskel P., Maintz D., Brandner S., Schramm J., Louis D.N., Wiestler O.D., von Deimling A. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropath Exp Neurol. 54:1995;91-95.
18. Yong W.H., Chou D., Ueki K., Harsh G., von Deimling A., Gusella J.F., Mohrenweiser H.W., Louis D.N. Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112. J Neuropath Exp Neurol. 54:1995;622-626.
19. Rosenberg J.E., Lisle D.K., Burwick J.A., Ueki K., von Deimling A., Mohrenweiser H.W., Louis D.N. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene. 13:1996;2483-2485.
20. Rabbits T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
21. Knight J.C., Reeves B.R., Kearney L., Monaco A.P., Lehrach H., Cooper C.S. Localization of the synovial sarcoma t(X;18) (p11,2;q11,2) breakpoint by fluorescence in situ hybridization. Hum Mol Genet. 1:1992;633-637.
22. Clark J., Rocques P.J., Crew A.J., Gill S., Shipley J., Chan A.M., Gusterson B.A., Cooper C.S. Identification of novel genes SYT and SSX involved in the t(X;18)(p11,2;q11,2) translocation found in human synovial sarcoma. Nat Genet. 7:1994;502-508.
23. Crew A.J., Clark J., Fisher C., Gill S., Grimer R., Chand A., Shipley J., Gusterson B.A., Cooper C.S. Fusion of SYT to two genes SSX1 and SSX2 encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J. 14:1995;2333-2340.
24. Ohta M., Inoue H., Cotticelli M., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T., Croce C., Huebner K. The FHIT gene spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint is abnormal in digestive tract cancers. Cell. 84:1996;587-597.
25. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., De J.P., Rouleau G., Aurias A., Thomas G. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 359:1992;162-165.
26. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher F.S., Emanuel B.S., Rovera G., Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nat Genet. 5:1993;230-235.
27. Aman P., Ron D., Mandahl N., Fioretos T., Heim S., Arheden K., Willen H., Rydholm A., Mitelman F. Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosom Cancer. 5:1992;278-285.
28. Still I.H., Roberts T., Cowell J.K. Fine structure physical mapping of a 1.9 Mbp region of chromosome 13q12. Ann Hum Genet. 61:1997;15-24.
29. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning: A Laboratory Manual. ed 2, Cold Spring Harbor Laboratory Press, New York.
30. Lewis B.C., Shah N.P., Braun B.S., Denny C.T. A yeast artificial chromosome fragmentation vector based on lysine-2. GATA. 9:1992;86-90.
31. Roberts T., Chernova O.B., Cowell J.K. Molecular characterization of the 1p22 breakpoint region spanning the constitutional translocation breakpoint in a neuroblastoma patient with a t(1;10)(p22;q21) rearrangement. Cancer Genet Cytogenet. 100:1998;10-20.
32. Kempski H., MacDonald D., Michalski A.J., Roberts T., Goldman J.M., Cross C.P., Cowell J.K. Localization of the 8;13 translocation breakpoint associated with myeloproliferative disease to a 1,5Mbp region of chromosome 13. Genes Chromosom Cancer. 12:1995;283-287.
33. Stein G.H. T98G. an anchorage independent human tumor cell line that exhibits stationary phase G1 arrest in vitro J Cell Physiol. 99:1979;43-54.
34. Ashworth L.K., Batzer M.A., Brandriff B., Branscomb E., de Jong P., Garcia E., Garnes J.A., Gordon L.A., Lamerdin J.E., Lennon G., Mohrenweiser H., Olsen A., Slezak T., Carranp A.V. An integrated metric physical map of human chromosome 19. Nat Genet. 11:1995;422-427.
35. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M., Parsons R. PTEN, a putative protein tyrosine phophatase gene mutated in human brain, breast, and prostate cancer. Science. 275:1997;1943-1947.
36. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K.A., Lin H., Ligon A.H., Langford L.A., Baumgard M.L., Hattier T., Davis T., Frye C., Hu R., Swedlund B., Teng D.H.F., Tavtigian S.V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 15:1997;356-362.
37. Rasheed B.K., McLendon R.E., Friedman H.S., Friedman A.H., Fuchs H.E., Bigner D.D., Bigner S.H. Chromosome 10 deletion mapping in human gliomas. a common deletion region in 10q25 Oncogene. 10:1995;2243-2246.